Clinical Trial: Evaluation of Two Different Calcium Silicate Cements as a Treatment for Irreversible Pulpitis in Mature Molars

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07066410) titled 'Evaluation of Two Different Calcium Silicate Cements as a Treatment for Irreversible Pulpitis in Mature Molars' on June 30.

Brief Summary: This randomized controlled clinical trial aims to evaluate the effect of different calcium silicate cements-specifically Biodentine and EndoCem-on post-operative pain and treatment success in vital pulp therapy (VPT) for mature permanent molars diagnosed with irreversible pulpitis. VPT, as a conservative alternative to traditional root canal treatment.

This involves the removal of inflamed coronal pulp tissue and the preservation of healthy radicular pulp. A total of 50 patients will be randomly...